<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>To Keep Epipen Sales Up, Mylan Threatened States, Sued Making Bogus Claims</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2017/04/25/to-keep-epipen-sales-up-mylan-threatened-states-sued-making-bogus-claims.aspx</link><description>Few names in the pharmaceutical business are more infamous than Mylan. They made headlines in 2016 for aggressively inflating the price of their EpiPen products and gouged consumers of this lifesaving intervention with 400 percent price increases. The</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>